About the Authors
- Zhu Luo
-
Affiliation Institute of Drug Clinical Trials, West China Hospital, Sichuan University, Chengdu 610041, P. R. China
- Feng Nan
-
Affiliation Institute of Drug Clinical Trials, West China Hospital, Sichuan University, Chengdu 610041, P. R. China
- Jia Miao
-
Affiliation Institute of Drug Clinical Trials, West China Hospital, Sichuan University, Chengdu 610041, P. R. China
- Zhihui Chen
-
Affiliation Institute of Drug Clinical Trials, West China Hospital, Sichuan University, Chengdu 610041, P. R. China
- Mei Li
-
Affiliation Institute of Drug Clinical Trials, West China Hospital, Sichuan University, Chengdu 610041, P. R. China
- Maozhi Liang
-
* E-mail: wchscu@sohu.com
Affiliation Institute of Drug Clinical Trials, West China Hospital, Sichuan University, Chengdu 610041, P. R. China
Competing Interests
The study was funded by Beijing Furuikangzheng Pharmaceuticals Co. Ltd.(Beijing, People's Republic of China) and this company manufactures the febuxostat tablets tested in the trial. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: ZL M. Liang. Performed the experiments: FN ZC JM M. Li. Analyzed the data: ZL M. Liang. Contributed reagents/materials/analysis tools: FN ZC. Wrote the paper: ZL.